Company

Scintomics Molecular ATT

Pharmaceutical Manufacturing Fuerstenfeldbruck, Bayern, De 2 employees

Employees: 2
Contacts: 1
Emails: 1

sci-att.com LinkedIn

Scintomics Molecular ATT Overview

Headquarters: Fuerstenfeldbruck, Bayern, De
Website: sci-att.com
Industry: Pharmaceutical Manufacturing
Employees: 2
Founded: 2018
NAICS: Pharmaceutical and Medicine Manufacturing

Medicinal and Botanical Manufacturing

Pharmaceutical Preparation Manufacturing

Keywords

Tesla Dynamic Coils

About Scintomics Molecular ATT

Scintomics Molecular, Applied Theranostics Technologies (SCI-att) is a growing player in the radiopharmaceutical business with a particular strategic emphasis on providing unrestricted supply and support of proprietary and innovative tracer technology and non-IP protected precursors, such as PSMA I&T and next generation PSMA inhibitors for radioligand therapy such as siPSMA-14. The well-known GRP Module Series became part of SCI-att in 2020 when SCI-att took over the Module business from its parent company Scintomics, which has been selling and installing fully automated production systems for established radio-pharmaceuticals in clinical facilities around the world since 2006.

Scintomics Molecular ATT Contact Details

People in AeroLeads: 2
With contact data: 1
Email contacts: 1; 50.0% coverage

Scintomics Molecular ATT Org Chart

Sample employees and titles

Name	Title	Location	Contact
Andrea Maugg	CEO Bei Scintomics Molecular Att	Fürstenfeldbruck, Bavaria, Germany	View
Philipp Spatz	Medicinal Chemist, Dr. Rer. Nat.	Olching, Bavaria, Germany	Email